PMPRB Update: Jurisdiction extends to CSPs effective June 30; coming into force of Patented Medicines Regulations and Guidelines delayed to January 2022

Smart & Biggar
Contact

The coming into force of the amended Patented Medicines Regulations has been delayed a third time, now until January 1, 2022.

The amendments, once in force, will add new price regulatory factors, revise the list of reference countries, and modify reporting requirements for particular categories of drugs (see our articles here and here regarding the amendments). The coming into force of the provisions relating to confidential third party rebates was previously delayed after those provisions were declared invalid by the Federal Court and found to be unconstitutional by the Quebec Superior Court. Appeals are pending in both cases.

The Patented Medicine Prices Review Board (PMPRB) Guidelines, which are intended to operationalize the amendments, are now similarly scheduled to take effect January 1, 2022. Innovative Medicines Canada and a number of pharmaceutical companies have commenced an application for judicial review in relation to the Guidelines.

The amendments to the Patent Act flowing from the Canada–European Union Comprehensive Economic and Trade Agreement Implementation Act (sections 45-58) that extend the PMPRB’s jurisdiction to encompass Certificates of Supplementary Protection will come into force on June 30, 2021, along with consequential amendments to the Patented Medicines Regulations and Patented Medicines Price Review Board Rules of Practice and Procedure.

Written by:

Smart & Biggar
Contact
more
less

Smart & Biggar on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.